{"id":11841,"date":"2022-10-27T17:08:05","date_gmt":"2022-10-27T14:08:05","guid":{"rendered":"https:\/\/www.robomarkets.com\/blog\/?p=11841"},"modified":"2024-01-31T16:59:56","modified_gmt":"2024-01-31T13:59:56","slug":"ipo-of-prime-medicine-the-largest-biotech-placement-in-2022","status":"publish","type":"post","link":"https:\/\/www.robomarkets.com.cy\/blog\/stock-market\/ipo-of-prime-medicine-the-largest-biotech-placement-in-2022\/","title":{"rendered":"Prime Medicine IPO: The Largest Biotech IPO in 2022"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Genetic engineering is a modern and very promising sphere of biotechnology. It unites the experience gained from biology, genetics, virology, chemistry, and other sciences to alter genotypes.  With artificial modifications and manipulations made to DNA and RNA using technology, organisms are given the desirable characteristics. This could cure numerous diseases.<\/p>\n\n\n\n

In this respect, the stocks<\/a> of companies that undertake research and development initiatives in this sphere are popular among investors. Today we will present one of these companies. Prime Medicine, Inc. placed its shares on the NASDAQ on 20 October 2022 under the ticker PRME.<\/p>\n\n\n\n

\"Prime
Prime Medicine logo<\/figcaption><\/figure>\n\n\n\n
\n
\n
\n

Try trading in the high-tech R StocksTrader<\/span> terminal!<\/p>\n

Gain access to real stocks, advanced charts, and a free trading strategy builder<\/p>\n <\/div>\n

\n \"partner-programme\"\n <\/div>\n Open R StocksTrader Account<\/a>\n <\/div>\n
\n \"partner-programme\"\n <\/div>\n <\/div>\n\n\n\n

<\/span><\/a>What we know about Prime Medicine<\/span><\/h2>\n\n\n\n

Prime Medicine Inc. is a biotech company that develops a new class of differentiated genetic drugs for curing complex diseases. It works on implementing the Prime Editing technology of gene editing.<\/p>\n\n\n\n

Prime Medicine states that Prime Editing can potentially correct about 90% of all known malignant genetic mutations in many human organ cells. Drugs based on this technology could help patients if approved by the regulator.<\/p>\n\n\n\n

\"Prime
Prime Medicine's business<\/em><\/em><\/figcaption><\/figure>\n\n\n\n

According to Prime Editing developers, the next-generation technology could be effective against the following diseases:<\/p>\n\n\n\n